A major advance in cancer research is arising with the use of VHH fragments to re-engage damaged p53. This vital malignant protector protein is frequently inactivated in many kinds of malignancies, resulting https://esocialmall.com/story7463705/mini-antibodies-restore-tumor-suppressor-p53-the-potential-hope-for-cancer-treatment